Newsroom

Samples on dry ice.
News
The Helmholtz Association is pooling its commitment to prevention research with the launch of the Helmholtz Health Prevention Task Force. In a strategy paper published in Nature Medicine, the expert committee outlines initial concepts for more effectively integrating prevention into medical practice.
22.04.2025
Felix Deschner in the lab
News
The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome these resistances, drugs with novel mode of action are urgently needed. Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have now uncovered the mode of action of a promising class of natural products – the chlorotonils. These molecules simultaneously target the bacterial cell membrane and the bacteria’s ability to produce proteins, enabling them to break through resistance. The team published its findings in the journal Cell Chemical Biology.
15.04.2025
Future Day
News
Today, around 60 schoolchildren from grades 5 to 9 visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig to gain an insight into the work of a modern research institution. They were able to immerse themselves in the fascinating world of science in a total of eight different departments.
03.04.2025
Group image
News
On March 17 and 18, 2025, the kick-off meeting of the INFRALINK network took place at the Helmholtz Centre for Infection Research (HZI) in Braunschweig. Six partner institutions will establish a network to facilitate infection research between the public health service and research institutions. The project is being funded by the Volkswagen Foundation with 500,000 euros.
02.04.2025
Josef Penninger
News
Science is currently facing major challenges in the United States – and with noticeable impacts on Europe. Research budgets have been and continue to be cut and jobs lost, even in key areas such as health and infectious diseases. A viewpoint from Josef Penninger, Scientific Director of the Helmholtz Centre for Infection Research.
01.04.2025
Electron microscope image
News
An international research group led by the Helmholtz Centre for Infection Research (HZI) has discovered a promising new drug candidate against severe lung infections caused by the hospital germ Staphylococcus aureus. The study, which has just been published in Cell Host & Microbe, describes for the first time how small molecules from the quinoxalinedione class specifically block the bacterial toxin α-hemolysin – a key trigger of tissue damage and inflammation.
01.04.2025

HZI in the media

tools.” – Dr. Anya Sharma, Virologist at the Helmholtz Centre for Infection Research.

 

Looking Ahead: The Long-Term Implications of

08.01.2026
|
ARCHYDE

Beisel at Germany's Helmholtz Institute for RNA-based Infection Research in Würzburg and Dirk Heinz at the Helmholtz Center for Infection

07.01.2026
|
News Medical

... basierte Infektionsforschung (HIRI) in Würzburg nachweisen. Gemeinsam mit dem Braunschweiger Helmholtz-Zentrum für Infektionsforschung ...

07.01.2026
|
DeutschesGesundheitsPortal

consisting of Hannover Medical School (MHH), the Helmholtz Centre for Infection Research (HZI) in Braunschweig, and the Leibniz Institute in

07.01.2026
|
Trading View

... haben nun die Studienautoren vom HIRI ‒ einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

02.01.2026
|
Biermann Medizin

... bis zur Medikamentenentwicklung", sagt Josef Penninger, wissenschaftlicher Geschäftsführer des HZI und Leiter der Abteilung Innovative ...

30.12.2025
|
Tagesschau

Erkrankungen. Eine Arbeitsgruppe des TWINCORE Helmholtz Zentrum für Infektionsforschung ( HZI ) und der Medizinischen Hochschule Hannover ( ...

30.12.2025
|
Deutsches Ärzteblatt

Forschungsteam um Tobias Gulder, Abteilungsleiter am Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS), ist es ...

29.12.2025
|
Biermann Medizin

... des Leibniz Lungenzentrums Borstel, des Helmholtz-Instituts für Pharmazeutische Forschung Saarland sowie weiterer wissenschaftlicher ...

29.12.2025
|
Das PTA Magazin

Dr. Rolf Müller, Managing Director of Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), were both named laureates of the

22.12.2025
|
Research Information

... ein Interview mit Josef Penninger geführt . Er ist wissenschaftlicher Geschäftsführer des Helmholtz-Zentrum für Infektionsforschung in ...

21.12.2025
|
T3N

Forschende vom Würzburger Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz- ...

17.12.2025
|
Verband Deutscher Biologen e.V.

Register now for the HZI-Newsletter